07/10/2004
ReGen Therapeutics Plc (the ‘Company’) announces that on 6 October 2004 it received notification from Mr P. Garrod that he is beneficially interested in 30,000,000 ordinary shares of the Company representing 10.7% of the current issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel. 020 7960 6007